2008 Conference Publication Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosisCrawford, D. H. G., Murphy, T. L., Ramm, L. E., Fletcher, L. M., Clouston, A. D., Anderson, G. J., Subramaniam, V. N., Powell, L. W. and Ramm, G. A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. AGW 2008: Australian Gastroenterology Week 08, Brisbane, QLD, Australia, 22-25 October 2008. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. doi: 10.1111/j.1440-1746.2008.05613.x |
2008 Conference Publication Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosisCrawford, Darrell H., Murphy, Therese L., Ramm, Louise E., Fletcher, Linda M., Clouston, Andrew D., Anderson, Gregory J., Subramaniam, V. Nathan, Powell, Lawrie W. and Ramm, Grant A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. The Liver Meeting 2008: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, U.S.A., 31 October-4 November 2008. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/hep.22641 |
2008 Conference Publication Combined deletion of HFE and transferrin receptor 2 results in a dramatic disruption in hepcidin regulation and severe iron overloadSubramaniam, V. N., Summerville, L., Crampton, E. M., Frazer, D. M., Anderson, G. J. and Wallace, D. F. (2008). Combined deletion of HFE and transferrin receptor 2 results in a dramatic disruption in hepcidin regulation and severe iron overload. Australian Gastroenterology Week, Brisbane, QLD, Austalia, 22-25 October 2008. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x |
2008 Conference Publication Functional consequences of disease causing mutations in the juvenile haemochromatosis geneWallace, D. F., Leddy, E., Summerville, L., Crampton, E. M. and Subramaniam, V. N. (2008). Functional consequences of disease causing mutations in the juvenile haemochromatosis gene. Australian Gastroenterology Week, Brisbane, QLD, Austalia, 22-25 October 2008. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x |
2007 Journal Article Non-HFE haemochromatosisWallace, Daniel F. and Subramaniam, V. Nathan (2007). Non-HFE haemochromatosis. World Journal of Gastroenterology, 13 (35), 4690-4698. doi: 10.3748/wjg.v13.i35.4690 |
2007 Conference Publication Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expressionTheurl, M., Theurl, I., Hochegger, K., Obrist, P., Subramaniam, N., van Rooijen, N., Schuemann, K. and Weiss, G. (2007). Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression. HOBOKEN: WILEY-LISS. |
2007 Journal Article A novel mutation in ferroportin implicated in iron overloadWallace, Daniel F., Dixon, Jeannette L., Ramm, Grant A., Anderson, Gregory J., Powell, Lawrie W. and Subramaniam, V. Nathan (2007). A novel mutation in ferroportin implicated in iron overload. Journal of Hepatology, 46 (5), 921-926. doi: 10.1016/j.jhep.2007.01.033 |
2007 Journal Article Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overloadWallace, Daniel F., Summerville, Lesa and Subramaniam, V. Nathan (2007). Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. Gastroenterology, 132 (1), 301-310. doi: 10.1053/j.gastro.2006.11.028 |
2007 Conference Publication Liver-specific deletion of the transferrin receptor 2 gene in mice leads to iron overloadSubramaniam, V. N., Summerville, L. and Wallace, D. F. (2007). Liver-specific deletion of the transferrin receptor 2 gene in mice leads to iron overload. International BioIron Society Meeting, Kyoto, Japan, 1-6 April 2007. Hoboken, NJ, United States: John Wiley & Sons, Inc.. doi: 10.1002/ajh.20964 |
2007 Conference Publication Ferroportin : Membrane topologyand characterisation of mutationsWallace, D. F. and Subramaniam, V. N. (2007). Ferroportin : Membrane topologyand characterisation of mutations. International BioIron Society Meeting, Kyoto, Japan, 1-6 April 2007. Hoboken, NJ, United States: John Wiley & Sons, Inc.. doi: 10.1002/ajh.20964 |
2007 Conference Publication Disease causing mutations of transferrin receptor 2 cause its intracellular retentionSubramaniam, V. N., Summerville, L. and Wallace, D. F. (2007). Disease causing mutations of transferrin receptor 2 cause its intracellular retention. International BioIron Society Meeting, Kyoto, Japan, 1-6 April 2007. Hoboken, NJ, United States: John Wiley & Sons, Inc.. doi: 10.1002/ajh.20964 |
2007 Conference Publication Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overloadWallace, D. F., Summerville, L. and Subramaniam, V. N. (2007). Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. 42th Annual Meeting of the European Association for the Study of the Liver, Barcelona, Spain, 11-15 April 2007. AMSTERDAM: Elsevier. doi: 10.1016/S0168-8278(07)61717-6 |
2006 Journal Article The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosisWalsh, Alissa, Dixon, Jeannette L., Ramm, Grant A., Hewett, David G., Lincoln, Douglas J., Anderson, Gregory J., Subramaniam, V. Nathan, Dodemaide, Julian, Cavanaugh, Juleen A., Bassett, Mark L. and Powell, Lawrie W. (2006). The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clinical Gastroenterology and Hepatology, 4 (11), 1403-1410. doi: 10.1016/j.cgh.2006.07.009 |
2006 Conference Publication Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasisWallace, D. F., Summerville, L. and Subramaniam, V. N. (2006). Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasis. OXFORD: BLACKWELL PUBLISHING. |
2006 Journal Article Clinical expression of C282Y hornozygous HFE haernochromatosis at 14 years of ageRossi, Enrico, Wallace, Daniel F., Subramaniam, V. Nathan, St Pierre, Timothy G., Mews, Catherine and Jeffrey, Gary P. (2006). Clinical expression of C282Y hornozygous HFE haernochromatosis at 14 years of age. Annals of Clinical Biochemistry, 43 (3), 233-236. doi: 10.1258/000456306776865197 |
2006 Journal Article Screening for hemochromatosis in asymptomatic subjects with or without a family historyPowell, Lawrie W., Dixon, Jeannette L., Ramm, Grant A., Purdie, David M., Lincoln, Douglas J., Anderson, Gregory J., Subramaniam, V. Nathan, Hewett, David G., Searle, Jeffrey W., Fletcher, Linda M., Crawford, Darrell H., Rodgers, Helen, Allen, Katrina J., Cavanaugh, Juleen A. and Bassett, Mark L. (2006). Screening for hemochromatosis in asymptomatic subjects with or without a family history. Archives of Internal Medicine, 166 (3), 294-301. doi: 10.1001/archinte.166.3.294 |
2006 Conference Publication Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasisWallace, D. F., Summerville, L. and Subramaniam, V. N. (2006). Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasis. Australian Gastroenterology Week, Adelaide, SA, Australia, 11-14 October 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x |
2006 Journal Article Purification and partial characterisation of recombinant human hepcidinWallace, Daniel F., Jones, Marc D., Pedersen, Palle, Rivas, Lucy, Sly, Lindsay I. and Subramaniam, V. Nathan (2006). Purification and partial characterisation of recombinant human hepcidin. Biochimie, 88 (1), 31-37. doi: 10.1016/j.biochi.2005.07.003 |
2006 Conference Publication The clinical relevance of compound heterozygosity for the haemochromatosis mutations (C282Y/H63D)Walsh, A., Dixon, J. L., Ranun, G. A., Hewett, D. G., Lincoln, D., Anderson, G. L., Subramaniam, N., Dodermaide, J., Bassett, M. and Powell, L. (2006). The clinical relevance of compound heterozygosity for the haemochromatosis mutations (C282Y/H63D). Digestive Disease Week Meeting/107th Annual Meeting of the American Gastroenterlogical Association, Los Angeles, CA, United States, 20-25 May 2006. PHILADELPHIA: W.B. Saunders. |
2005 Journal Article Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytesWallace, Daniel F., Summerville, Lesa, Lusby, Patricia E. and Subramaniam, V. Nathan (2005). Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytes. Journal of Hepatology, 43 (4), 720-728. doi: 10.1016/j.jhep.2005.02.047 |